The gut microbiota and irritable bowel syndrome: friend or foe?

» By Ghoshal UC, et al

(January 2012) Progress in the understanding of the pathophysiology of irritable bowel syndrome (IBS), once thought to be a purely psychosomatic disease, has advanced considerably and low-grade inflammation and changes in the gut microbiota now feature as potentially important…

Read more: http://www.hindawi.com/journals/iji/2012/151085/



Decentral gene expression analysis for ER+/Her2 breastcancer: results of a proficiency testing program for the EndoPredict assay

» By Denkert C, et al

(March 2012) Gene expression profiles provide important information about the biology of breast tumors and can be used to develop prognostic tests…

Read more: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306560/?tool=pubmed



Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs

» By Brown CA, et al

(2012) Since the Pap test was introduced in the 1940s, there has been an approximately 70% reduction in the incidence of squamous cell cervical cancers in many developed countries…

Read more: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317214/?tool=pubmed



Breast cancer medications and vision: effects of treatments for early-stage disease

» By Eisner, Alvin, et al

(May 2011) This review concerns the effects on vision and the eye of medications prescribed at three phases of treatment for women with early-stage breast cancer…

Read more: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205820/pdf/ncer36-867.pdf



The effect of breast-feeding duration on bone mineral density in postmenopausal Turkish women: a population-based study

» By Yazici, Selma, et al

(June 2011) Introduction: In the present study, we investigated the effects of breast-feeding time on bone mineral density (BMD) later in life. Material and methods: The current…

Read more: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258757/?tool=pubmed



Biological characteristics and medical treatment of breast cancer in young women—a featured population: results from the NORA study.

» By Pronzato, P., et al

(October 2011) Background. The present paper described the biological characteristics and clinical behavior of young women in the cohort NORA study Patients and Methods. From 2000-2002, patients…

Read more: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275934/pdf/IJBC2011-534256.pdf



Role of dietary fatty acids in mammary gland development and breast cancer

» By Mira MacLennan and David WL Ma

(October 2010) Breast cancer is the most common cancer among women worldwide. Estimates suggest up to 35% of cases may be preventable through diet and lifestyle modification…

Read more: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096965/?tool=pubmed



Caring for others, but not themselves: implications for health care interventions in women with cardiovascular disease

» By DiGiacomo M, et al

(May 2011) Cardiovascular disease is the largest killer of women internationally and women often suffer inferior outcomes following an acute cardiac event as compared to men. A…

Read more: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169919/?tool=pubmed



Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physicians

» By R Heisey, et al

(October 2011) Many women with symptoms suggestive of a breast cancer diagnosis delay presentation to their family physician. Although factors associated with delay have been well described…

Read more: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185904/?tool=pubmed



Safety evaluation of algal oil from Schizochytrium sp.

» By I Fedorova-Dahms, et al

(January 2011) The safety of Algal Oil from Schizochytrium sp. was evaluated by testing for gene mutations, clastogenicity and aneugenicity, and in a subchronic 90-day Sprague–Dawley rat…

Read more: http://www.sciencedirect.com/science/article/pii/S0278691510006095